A simultaneous blockade of IL-6 and this signaling led to an increase in the expression of INF-γ produced by CD4+ T cells and consequent enhancement of anti-PD-1 therapy in a mouse model of melanoma [162]. This evidence concerns the gene IL6 and melanoma.